Ironwood Pharmaceuticals (IRWD) Finished Goods (2017 - 2019)

Ironwood Pharmaceuticals has disclosed Finished Goods across 3 years of filings, most recently posting $191000.0 for Q4 2019.

• Finished Goods for Q4 2019 came in at $191000.0, changed N/A year-over-year; the trailing twelve-month figure through Dec 2019 was $191000.0 (changed N/A YoY), and the FY2019 annual result was $191000.0, changed N/A from the prior year.
• Finished Goods came in at $191000.0 for Q4 2019 at Ironwood Pharmaceuticals, down from $457000.0 in the prior quarter.
• In the past five years, Finished Goods ranged from a high of $1.4 million in Q1 2018 to a low of $76000.0 in Q3 2018.
• The 3-year median for Finished Goods is $479000.0 (2017), against an average of $589428.6.
• Across the five-year window, Finished Goods slumped 84.13% in 2018 and soared 501.32% in 2019, its largest moves.
• Ironwood Pharmaceuticals' Finished Goods stood at $735000.0 in 2017, then plunged by 89.66% to $76000.0 in 2018, then jumped by 151.32% to $191000.0 in 2019.
• The last three Finished Goods figures came in at $191000.0 (Q4 2019), $457000.0 (Q3 2019), and $76000.0 (Q3 2018), per Business Quant data.